Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
C. Chen
Observed name:
Changlan Chen
Institution:
First Affiliated Hospital of Xi'an Jiaotong University
Observed institutions:
Fujian Medical University,
Xiamen University,
BeiGene (China),
First Affiliated Hospital of Xi'an Jiaotong University,
Fujian Provincial Cancer Hospital,
Tang Du Hospital,
Union Hospital,
Air Force Medical University
show all 8
ORCID:
0009-0000-8084-4040
Observed ORCID:
0009-0000-8084-4040
OpenAlex ID:
A5111350029
VP1-2024: RATIONALE-315: Event-free survival (EFS) and overall survival (OS) of neoadjuvant tislelizumab (TIS) plus chemotherapy (CT) with adjuvant TIS in resectable non-small cell lung cancer (NSCLC)
2024
·
D. Yue
, W. Wang
, et al.
·
Annals of Oncology
·
50
Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma
2017
·
J. Chen
, T. Su
, et al.
·
Clinical & Translational Oncology
·
26
Causal effects of diabetic retinopathy on depression, anxiety and bipolar disorder in the European population: a Mendelian randomization study
2023
·
C. Chen
, Y. Lan
, et al.
·
Journal of Endocrinological Investigation
·
19
865P A phase II study of sintilimab plus anlotinib for Chinese patients (pts) with persistent, recurrent, or metastatic cervical cancer (CC)
2020
·
Q. Xu
, C. Chen
, et al.
·
Annals of Oncology
·
7
PDF
OA 16.04 Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients
2017
·
D. Yue
, S. Xu
, et al.
·
Journal of Thoracic Oncology
·
7
PDF
79P SETD2 a potential tissue-agnostic predictive biomarker for ICIs in solid tumors
2021
·
Y. Chen
, X. Zheng
, et al.
·
Annals of Oncology
·
5
403O Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT as first-line (1L) treatment for recurrent or metastatic nasopharyngeal cancer (NPC): 3-year follow-up from the RATIONALE-309 study
2024
·
W.F. Fang
, J. Pan
, et al.
·
Annals of Oncology
·
2
PDF
JCES 01.10 The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer
2017
·
S. Xu
, W. Zhong
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
Incidence, Risk Factors, and Treatment of Autoimmune Cytopenia Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
2025
·
Changlan Chen
, Yingying Wang
, et al.
·
Journal of Transplantation
·
1
PDF
774P Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial
2021
·
Q. Xu
, C. Chen
, et al.
·
Annals of Oncology
·
1
Depicting Distant Metastatic Risk by Refined Subgroups Derived From the 8th Edition Nasopharyngeal Carcinoma TNM
2019
·
Q. Guo
, T. Lu
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
Depicting Distant Metastatic Risk by Refined Subgroups Derived From the 8th Edition Nasopharyngeal Carcinoma TNM
2019
·
Q. Guo
, T. Lu
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
AMIGO2 Promotes The Proliferation And Metastasis Of Nasopharyngeal Carcinoma Cells By Activating The MAPK Signaling Pathway
2020
·
W. Ye
, C. Chen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
The Prognostic Value of Plasma Uric Acid and Tumor Response to Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
2020
·
Z. Wu
, C. Chen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Comprehensive Analysis of Key Genes Associated with ceRNA Networks in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis
2020
·
H. Xinyi
, C. Chen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Pcv147 Data Quality Evaluation of 5 Municipal and Provincial Claims Databases of Fujian Province in China
2019
·
C. Chen
, X. Xie
, et al.
·
Value in Health
PDF
Gemcitabine Based Induction Chemotherapy may Improve the Survival of Stage IVA Nasopharyngeal Carcinoma
2018
·
J. Zong
, J. Pan
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Significance of pre-treatment F-18 FDG PET/CT parameters in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
2018
·
Y. Huang
, C. Chen
, et al.
·
Annals of Oncology
Proteomic comparison based on 18FDG-PET/CT defined metabolic tumor volume in non-metastatic nasopharyngeal carcinoma
2018
·
C. Chen
, L. Li
, et al.
·
Annals of Oncology
P2.03-047 The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer
2017
·
S. Xu
, W. Zhong
, et al.
·
Journal of Thoracic Oncology
Show more works
View as search
Works count:
20
Citation count:
122
H-index:
5
I10-index:
3
Year
Topic
Type